|
Sign In to gain access to subscriptions and/or personal tools.
|
Effects of Lymphotoxin β Receptor Blockade on Intestinal Mucosal Immunity
Woodae Kang, MD, PhD ,
Kenneth A. Kudsk, MD*, ,
Yoshifumi Sano, MD ,
Jinggang Lan, PhD ,
Fu Yang-Xin, PhD ,
F. Enrique Gomez, PhD and
Yoshinori Maeshima, MD
From the * Veterans Administration Surgical
Services, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin;
the Department of Surgery, University of
Wisconsin–Madison College of Medicine and Public Health, Madison,
Wisconsin; and University of Chicago
Department of Pathology, Chicago, Illinois
Correspondence: Kenneth A. Kudsk, MD, 600 Highland Ave, H4/736 CSC, Madison,
WI 53792-7375. Electronic mail may be sent to
kudsk{at}surgery.wisc.edu.
Background: Mucosal addressin cellular adhesion molecule-1
(MAdCAM-1) directs lymphocyte migration into gut-associated lymphoid tissue
(GALT) through Peyer's patches (PPs). Parenteral nutrition (PN) impairs
mucosal immunity by reducing PPs MAdCAM-1 expression, T and B cells in GALT,
and intestinal and respiratory immunoglobulin (Ig) A levels. We previously
showed that PN reduces lymphotoxin β receptor blockade (LTβR) in PPs
and intestine, and that stimulation with LTβR agonist antibodies reverses
these defects. To confirm that LTβR regulates transcription of MAdCAM-1
message and more fully understand the effects of LTβR on MAdCAM-1
function within the mucosal immune system, we studied the effect of LTβR
blockade with a chimeric LTβR Ig-fusion protein on MAdCAM-1 mRNA levels,
PP lymphocyte mass and IgA levels in the intestinal and respiratory tracts.
Methods: Mice were cannulated and killed 3 days after receiving chow
+ control Ig, chow + LTβR-Ig fusion protein (100 µg IV), or PN +
control Ig. The PPs of half of the animals were processed for lymphocyte
count, and the other half were processed for complementary DNA and subsequent
polymerase chain reaction (PCR). mRNA levels of MAdCAM-1 were determined by
real-time PCR; intestinal and respiratory IgA levels were measured by ELISA.
Results: PN significantly reduced PP lymphocyte mass, MAdCAM-1 mRNA,
and intestinal IgA. As anticipated, LTβR blockade significantly decreased
PP cells and MAdCAM-1 mRNA, but not intestinal IgA because chow feeding was
maintained. Both LTβR blockade and PN decreased nasal IgA, but not
significantly. Conclusions: LTβR blockade in chow animals
significantly reduces transcription of MAdCAM-1 gene and PPs lymphocyte mass.
These data implicate inadequate LTβR signaling as a major mechanism for
decreased GALT cells with lack of enteral stimulation, and further establish
the role of LTβR in the mucosal immune system.
Parenteral nutrition (PN) with lack of enteral nutrition increases the
incidence of pneumonia and intraabdominal abscesses in critically injured
patients.1,2
According to the common mucosal immune system hypothesis, the Peyer's patches
(PPs) of the gut-associated lymphoid tissue (GALT) are considered the major
inductive site for initiation of antigen-specific immunoglobulin (Ig) A
production. Naïve T and B cells migrate from the circulation into PPs,
are sensitized to antigens processed in the PPs, and are distributed
via the systemic circulation to the lamina propria of intestinal and
extraintestinal (such as the respiratory tract) mucosal sites after passing
through mesenteric lymph nodes and the thoracic
duct.3 In these
lamina propria effector sites, the sensitized T and B cells cooperate to
produce antigen-specific dimeric IgA, which serves as the antigen-specific
immune defense at mucosal surfaces in the form of secretory
IgA.4
PN with lack of enteral nutrition reduces the absolute numbers of
intraepithelial and lamina propria lymphocytes and
PPs,5 decreases the
levels of interleukin (IL)-4 and IL-6 (2 important Th2-type IgA-stimulating
cytokines) in the lamina
propria,6 and
reduces intestinal and respiratory tract IgA
levels.7 The overall
effect of these changes destroys both antiviral and antibacterial respiratory
defenses.8,9
These effects can be traced back to initial effects of PN on mucosal addressin
cellular adhesion molecule-1 (MAdCAM-1). MAdCAM-1, expressed on the high
endothelial venules of PPs, is a key molecule that regulates the traffic of
lymphocytes into the mucosal immune
system.10,11
This molecule, together with chemokines produced locally, draws naïve T
and B cells into the PPs to start the process of mucosal immune protection.
Our prior work shows that the PN-induced GALT cell mass reductions initially
derive from decreased MAdCAM-1 mRNA and protein expression, reducing entry of
T and B cells into the
PPs.12 This effect
is reproducible by blocking MAdCAM-1 with a specific anti-MAdCAM-1
antibody.13
Lymphotoxin β receptor (LTβR) signaling plays a critical role in
PPs' organogenesis and regulation of both MAdCAM-1 expression and IL-4
production14–16
and it induces CCL20 chemokine expression through NF B in gut mucosal
cells.17 Chemokines
are molecules that stimulate the migration of cells into
tissues.18
LTβR is expressed on the surface of cells in the parenchyma and stroma of
most lymphoid organs but is conspicuously absent on T and B lymphocytes. One
of the ligands for LTβR is lymphotoxin (LT 1β2), which is
transiently expressed on the surface of activated T and B lymphocytes.
Receptor ligation leads to activation of 2 distinct forms of NF B and
expression of genes involved in regulating immune processes that contribute to
cell survival, cell migration, and other
events.15 We
previously showed that PN decreases LTβR expression in the PPs and
intestine and that administration of a stimulatory (agonistic) antibody to
LTβR reversed the PN-induced decrease in PPs lymphocyte count and
intestinal IgA.19
The purpose of this study was to describe the relationship between LTβR
signaling with the PN-induced impaired mucosal immunity by specifically
blocking LTβR to further our investigation of the mechanism of PN-induced
MAdCAM-1 changes. For this reason, we examined effects of LTβR blockade
on PPs lymphocyte count, intestinal and upper respiratory IgA levels, PPs
MAdCAM-1 gene expression, and the gene expression of 2 chemokines (CCL20 and
CXCL12) important in cell migration in chow-fed mice and compared them to PN
feeding.
 |
MATERIALS AND METHODS
|
|---|
Animals
All experimental protocols were approved by the Animal Care and Use
Committee of the University of Wisconsin–Madison and Middleton Veterans
Administration Hospital, Madison. Six-week-old, male, Institute of Cancer
Research mice (Harlan, Indianapolis, IN) were used for the experiments. The
mice were kept in an environment under controlled temperature, humidity, and
light cycle (12-hour light/12-hour dark). They were acclimatized for 1 week
and fed a standard mouse chow (PMI Nutrition International, St. Louis, MO)
ad libitum before protocol entry. During feeding protocol, mice had
free access to water and were individually housed in metal metabolism cages
with wire grid floors to eliminate coprophagia.
Feeding and Experimental Protocol
Forty-three mice received central venous catheters (0.3-mm ID and 0.6-mm
OD; Helix, Carpinteria, CA) under ketamine/acepromazine (100/10 mg/kg)
anesthesia as described in detail
previously.5–7
Catheterized mice were placed into metal metabolism cages and immediately
connected to infusion pumps. This procedure is an acceptable method of
nutrition support that does not induce physical and biochemical
stress.20 The mice
were given 0.9% saline at 4 mL/d for 48 hours through the catheter, with free
access to chow. After recovering from surgery for 2 days, the animals were
then randomly assigned to receive either 100 µg LTβR-Ig fusion protein
IV (LTβR-Ig, 100 µg in 250 µL PBS; a generous gift from Yang-Xin
Fu, Chicago University, Chicago, IL) or human IgG IV (100 µg in 250 µL
PBS; Sigma, St. Louis, MO) as control. The LTβR-Ig-treated mice continued
with chow ad libitum and 0.9% saline at 4 mL/d IV throughout the
study. The control Ig-treated mice were randomly assigned to either chow or IV
PN. The PN mice initially received 4 mL/d of PN and were advanced to a goal
rate of 10 mL/d by the third day of feeding. The PN solution contained 6.0%
amino acids, 34.9% dextrose (6002 kJ/L), electrolytes, and multivitamins, with
a nonprotein calorie/nitrogen ratio of 535.8 kJ/g nitrogen. After 3 days of
these dietary treatments, the animals were anesthetized with a
ketamine/acepromazine mixture and exsanguinated by cardiac puncture. The small
intestine was excised from the pylorus to terminal ileum and the mesenteric
fat and external vasculature were dissected away. Then, the intestinal lumen
was flushed by 20 mL calcium- and magnesium-free Hanks' balanced salt solution
(HBSS). Nasal washes were collected by 1-mL saline injection through an
18-gauge angiocath inserted into the tracheal lumen at the level of the
cricoid cartilage after a midline incision made over the ventral aspect of the
trachea slightly superior to the thoracic inlet; these washing fluids were
collected in plastic tubes and stored at –80°C. The PPs were also
removed from the intestine either for lymphocyte cell count (see below) or
frozen in liquid N2 and stored at –80°C for analysis of
mRNA by real-time polymerase chain reaction (PCR).
Cell Isolation
Lymphocyte isolation from the PPs was performed following the previously
described protocol, with minor
modifications.5 In
brief, the PPs were excised from the serosal side of the intestine and the
number was counted. Then, the PPs were teased apart with scissors and the
fragments were incubated with RPMI-1640 (Mediatech Inc, Herndon, VA)
containing collagenase (Sigma; 40 U/mL), 5% fetal bovine serum, 100 U/mL
penicillin-streptomycin, and 2 mmol/L D-glutamine for 1 h at
37°C with constant rocking. The tissue slurry was passed through a
100-µm nylon cell strainer and centrifuged at 1500 rpm for 5 minutes. The
cell pellet was resuspended in RPMI-1640 solution without collagenase. PP
lymphocyte number was determined by counting in a hemocytometer after trypan
blue staining.
IgA Quantification
IgA was measured in intestinal and nasal washes with a sandwich
ELISA,19 with a
polyclonal goat antimouse IgA (Sigma) to coat a plate, a myeloma mouse IgA as
standard (Sigma), and a peroxidase-conjugated goat antimouse IgA antibody
(Sigma).
RNA Isolation and PCR
RNA isolation and quantitation. Total RNA was isolated with TRIzol
Reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's
instructions. Briefly, the PP samples were homogenized with 1 mL of TRIzol and
the RNA was extracted with chloroform and precipitated with isopropanol. The
integrity of the RNA was checked with 1% agarose gels stained with ethidium
bromide by visualization of the 28S and 18S rRNA bands; its concentration was
determined by UV at 260 nm and stored at –80°C until required.
Reverse transcription. Total RNA was used for the synthesis of
single-strand complementary DNA (cDNA) using avian myeloblastoma virus reverse
transcriptase (AMV-RT). All reagents used for reverse transcription were from
Promega (Madison, WI). Total RNA (2 µg) was incubated for 5 minutes at
70°C with 1 µg of oligo(dT)15, chilled on ice for 5 minutes,
and further incubated for 1 hour at 42°C with 2.5 µL of a 40 mmol/L
deoxynucleotide triphosphates (dNTPs), 30 U of AMV-RT, 5 µL of 5x
AMV-RT buffer, and 40 U of ribonuclease inhibitor (RNasin) in a final volume
of 25 µL. Reactions were then heat inactivated at 70°C for 10 minutes
and the cDNA was stored at –20°C until analysis.
Gene expression by quantitative real-time PCR. Real-time PCR was
performed using a Rotor-Gene 3000 thermal cycling system (Corbett Research,
Sydney, Australia) with SYBR-Green I (Molecular Probes, Eugene, OR) as
fluorescent probe. Briefly, PCR reactions were performed with 2 µL of 1:10
diluted cDNA, 0.3 µmol/L each of forward and reverse primers
(Table I), and a cocktail
mixture containing MgCl2, SYBR-Green, and Platinum Quantitative PCR
Super-Mix-UDG (Invitrogen, Life Technologies) in a total volume of 10 µL.
The reaction mixture was preheated 2 minutes at 50°C and 2 minutes at
95°C; then heated for 45 cycles with 15 seconds at 95°C, 20 seconds at
58°C, 15 seconds at 72°C, and 15 seconds at 78°C; and followed by
melting curve analysis to establish product specificity. A standard curve was
constructed with 6-fold serial dilutions of cDNA from PPs in a chow-fed mouse,
and all reaction tubes were run in triplicate. The 6 points always showed a
strong linear relationship (R2 >0.99) with the
threshold cycle. Data from each tube were analyzed using Rotor-Gene 3000
Application Software 6.0 (Corbett Research), and the mRNA levels of the target
gene were obtained by plotting on the standard curve. The value of each gene
was normalized with the level of 18S rRNA as housekeeping gene.
Statistical Analyses
All values were expressed as mean ± SE. Statistical analysis was
performed by ANOVA, followed by the Fisher's protected least significant
difference post hoc test.
 |
RESULTS
|
|---|
Body Weight Change
There were no significant differences between groups in preexperiment body
weight (Table II). At the end
of the feeding protocol, PN-fed mice lost significantly more weight than the
chow-fed groups; there were no significant differences between chow + control
Ig and chow + LTβR-Ig groups. Chow-fed mice typically have 1.5 g of
residual feces, whereas the GI tracts of PN mice are empty. Therefore, the
body weight differences were exaggerated between PN and chowfed mice.
Lymphocytes Numbers in PPs
PP total lymphocyte counts were significantly lower in the chow +
LTβR-Ig (n = 6) and PN + control Ig (n = 8) mice compared with the chow +
control Ig (n = 6) group (Figure
1A). Chow + LTβR-Ig produced significantly higher total cell
counts compared with PN + control Ig mice. There were no significant
differences in the number of harvested PPs (chow + control Ig: 10.7 ±
0.7; chow + LTβR-Ig: 10.3 ± 0.8; and PN + control Ig: 10.4
± 0.6). Lymphocyte counts/PP were significantly decreased in the chow +
LTβR-Ig (n = 6) and the PN + control Ig (n = 8) mice compared with those
in the chow + control Ig (n = 6) group
(Figure 1B). There were
significantly higher lymphocyte counts/PP in chow + LTβR-Ig mice compared
with PN + control Ig mice.

View larger version (12K):
[in this window]
[in a new window]
|
FIGURE 1. Effects of lymphotoxin β receptor-immunoglobulin fusion protein
(LTβR-Ig) and PN on lymphocyte numbers in Peyer's patches (PPs). A, Total
lymphocyte numbers in PPs. B, Lymphocyte numbers/PP. *p < .05 vs chow +
control Ig. p< .05 vs chow + LTβR-Ig.
|
|
Quantitative mRNA Expression in the PPs
PP expression of MAdCAM-1, CCL20, and CXCL12 mRNA from 22 mice was analyzed
using quantitative real-time PCR. PP MAdCAM-1 mRNA expression was
significantly lower in the chow + LTβR-Ig (n = 6) and PN + control Ig (n
= 8) mice than in the chow + control Ig (n = 8) group (chow + control Ig >
PN + control Ig > chow + LTβR-Ig;
Figure 2). There was no
significant difference in MAdCAM-1 mRNA expression between PN + control Ig and
the chow + LTβR-Ig groups.

View larger version (13K):
[in this window]
[in a new window]
|
FIGURE 2. Effects of lymphotoxin β receptor-immunoglobulin fusion protein
(LTβR-Ig) and PN on gene expression of mucosal addressin cellular
molecule-1 (MAdCAM-1). The data are expressed as percent of chow + control Ig
group. *p < .05 vs chow + control Ig group.
|
|
mRNA expression of CCL20 and CXCL12 decreased in the chow + LTβR-Ig (n
= 6) and PN + control Ig (n = 8) mice compared with the chow + control Ig
group (n = 8; Figure 3). Though
the pattern of mRNA expression decrease in the 3 groups was similar to the
MAdCAM-1 results (chow + control Ig > PN + control Ig > chow +
LTβR-Ig), there were no significant differences between any groups in
CCL20 and CXCL12 mRNA expression.

View larger version (13K):
[in this window]
[in a new window]
|
FIGURE 3. Effects of lymphotoxin β receptor-immunoglobulin fusion protein
(LTβR-Ig) and PN on gene expression of CCL20 and CXCL12. The data are
expressed as percent of chow + control Ig group.
|
|
IgA Levels
The levels of intestinal IgA were similar in both chow + control Ig (n =
14) and chow + LTβR-Ig (n = 13) groups, whereas those in the PN + control
Ig mice (n = 16) were significantly reduced
(Figure 4).

View larger version (16K):
[in this window]
[in a new window]
|
FIGURE 4. Effects of lymphotoxin β receptor-immunoglobulin fusion protein
(LTβR-Ig) and PN on intestinal IgA levels. PN significantly reduced
intestinal IgA levels. LTβR-Ig administration did not decrease intestinal
IgA levels. *p < .05 vs chow + control Ig and chow + LTβR-Ig
group.
|
|
Nasal wash IgA levels were depressed in the chow + LTβR-Ig (n = 13)
and PN + control Ig (n = 16) mice compared with chow + control Ig mice (n =
14), but the results failed to reach statistical significance among any group
(Figure 5).

View larger version (14K):
[in this window]
[in a new window]
|
FIGURE 5. Effects of lymphotoxin β receptor-immunoglobulin fusion protein
(LTβR-Ig) and PN on nasal IgA levels.
|
|
 |
DISCUSSION
|
|---|
PPs are a primary sensitization site for naïve T and B lymphocytes
destined for the mucosal immune network. After the sensitized lymphocytes
mature or proliferate in mesenteric lymph nodes, they enter the thoracic duct,
spread via blood circulation, and localize to the intestine or other
extraintestinal mucosal effector
sites.4,21
There, the B cells differentiate into plasma cells capable of producing
secretory IgA,4
which is the major antigen-specific mucosal immune defense against
bacteria.
Experimentally, our work with GALT and the mucosal-associated lymphoid
tissue (MALT) in mice provides a logical framework to explain the
preponderance of clinical data demonstrating reductions in pneumonia when
critically injured patients are fed enterally rather than parenterally or not
at
all.1,2
In these models, animals fed parenterally, with no enteral stimulation,
exhibit impaired mucosal immunity, which is initially reflected in decreased
MAdCAM-1 expression in PPs, which ultimately results in reduced GALT cell
mass.12,13
Simultaneously, intestinal and respiratory tract IgA levels
drop.5,7,22
These changes induce functional defects in antiviral and antibacterial
respiratory defenses. Animals immune to respiratory challenge with the A/PR
(H1N1) influenza virus or Pseudomonas aeruginosa lose established
IgA-mediated respiratory immunity after parenteral feeding but not with chow
or a complex enteral
diet.8,9
Similarly, PN-fed mice fail to generate new antibody-forming cells in response
to an acute viral respiratory infection, which depresses the viral-specific
respiratory antibody
response.23–25
These defects are rapidly reversible with chow
refeeding.7
A unique combination of adhesion molecules and chemokines mediates
migration of T and B lymphocytes into PPs from the circulation. Lymphocytes
expressing both 4β7 and L-selectin on their
surface interact with MAdCAM-1 and intercellular adhesion molecule-1 (ICAM-1),
which are expressed on the high endothelial venules of the
PPs26 and initiate
rolling and the adhesion of the cells to the venous endothelium. MAdCAM-1 is
key to these interactions because MAdCAM-1 blockade by an antagonistic
antibody reduces PP and LP lymphocyte levels to those of PN-fed mice given no
enteral
stimulation.13
ICAM-1 blockade has no
effect.26 MAdCAM-1
is expressed in response to LTβR signaling after stimulation by
lymphotoxin.27–29
In this study, we demonstrate that inhibition of LTβR signaling
significantly decreases PPs lymphocyte number in toto or per PP, as
well as decreases PP MAdCAM-1 gene expression to levels similar to those of
PN-fed mice. These results support our hypothesis that lack of enteral
stimulation plus PN depresses LTβR expression, resulting in impaired
mucosal immunity. This is consistent with our previous data showing that
LTβR stimulation with an agonistic antibody reverses the lack of enteral
nutrition, with PN-induced depression in PP cell
counts.19
However, blockade with LTβR-Ig did not decrease lymphocytes in PPs to
levels of PN-feeding alone, and there are several potential explanations for
this observation. It is possible that trafficking-related adhesion molecules
other than MAdCAM-1 are reduced by PN but not by LTβR blockade. Because G
protein–coupled receptors induce integrin-dependent firm adhesion in
lymphocytes trafficking
process,11 PN might
strongly suppress these proteins, whereas LTβR blockade would not.
Second, maximal enteral stimulation with chow produces compensatory effects,
as we showed previously in our MAdCAM-1 blockade
experiment.13
Although MAdCAM-1 blockade reduced cells numbers in GALT, intestinal IgA
levels were not suppressed to PN levels. This implies that depressed MAdCAM-1
expression through LTβR signaling inhibition is a major mechanism for the
decreased PP lymphocytes' mass with PN, but additional factors other than cell
mass influence intestinal IgA levels. Those additional factors include
compensatory increases in intestinal IL-4 levels, which we noted in previous
work, which could blunt the overall effect of reduced cell
mass.30 How chow
stimulation maintained the IL-4 levels is unknown, but IL-4 is one of the Th-2
type IgA-stimulating cytokines affected by PN with lack of enteral
stimulation. In addition, enteral stimulation induces the release of
neuropeptides, including gastrin-releasing peptide, gastrin, and
cholecystokinin, which are known to support mucosal
immunity.31–36
Enteral stimulation induces formation of small lymphoid clusters, termed
isolated lymphoid follicles (ILF), which are associated with mucosal IgA
production in the small
intestine.37
Additional effects could be generated by altered bacterial
flora.38,39
Administration of LTβR-Ig reportedly reduces ILF formation induced by
oral toxin immunization after a short period of food
deprivation,27
whereas continuous oral feeding maintains IgA production in ILF by maintaining
normal bacterial flora. PPs are not a prerequisite to generation of
IgA-producing
cells.40
Additionally, lack of luminal nutrients seems to disrupt the transport system
of IgA from the basal surface of epithelial cells to the luminal
surface.24 Chow-fed
animals might be able to maintain any of these systems despite LTβR
signal blockade.
This work has some limitations, however. Our primary interest remains how
enteral stimulation reduces pneumonia in critically ill patients. Our prior
work demonstrated impaired antiviral and antibacterial defenses, presumably
due to impaired IgA-mediated mucosal defenses. This work sheds light on gene,
GALT cell, and IgA responses to LTβR blockade but does not test
alterations in the function of those defenses.
 |
SUMMARY
|
|---|
This work supports the importance of LTβR levels and LTβR's
stimulation in the maintenance of normal mucosal immunity. This stimulation is
lost under conditions in which there is no enteral stimulation. Taken together
with our pervious stimulatory agonist experiments, the key role of this
molecule on mucosal immunity in normal conditions is clear.
The study was supported by National Institutes of Health grant R01
GM53439.
Received for publication December 12, 2006.
Accepted for publication January 22, 2007.
- Kudsk KA, Minard G, Croce MA, et al. A randomized trial of
isonitrogenous enteral diets following severe trauma: an immune-enhancing diet
(IED) reduces septic complications. Ann Surg.1996; 224:531
–543.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kudsk KA, Croce MA, Fabian TC, et al. Enteral vs. parenteral
feeding: effects on septic morbidity following blunt and penetrating abdominal
trauma. Ann Surg. 1992;215:503
–513.[Web of Science][Medline]
[Order article via Infotrieve]
- Roux ME, McWilliams M, Phillips-Quagliata JM, Lamm ME.
Differentiation pathway of Peyer's patch precursors of IgA plasma cells in the
secretory immune system. Cell Immunol.1981; 61:141
–153.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M,
Kiyono H. The mucosal immune system: from fundamental concepts to vaccine
development. Vaccine.1992; 10:75
–88.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Li J, Kudsk KA, Gocinski B, Dent D, Glezer J, Langkamp-Henken B.
Effects of parenteral and enteral nutrition on gut-associated lymphoid tissue.J Trauma.
1995;39:44
–52.[Web of Science][Medline]
[Order article via Infotrieve]
- Wu Y, Kudsk KA, DeWitt RC, Tolley EA, Li J. Route and type of
nutrition influence IgA-mediating intestinal cytokines. Ann
Surg. 1999;229:662
–667.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- King BK, Li J, Kudsk KA. A temporal study of TPN-induced changes in
gut-associated lymphoid tissue and mucosal immunity. Arch Surg.1997; 132:1303
–1309.[Abstract/Free Full Text]
- Kudsk KA, Li J, Renegar KB. Loss of upper respiratory tract
immunity with parenteral feeding. Ann Surg.1996; 223:629
–638.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- King BK, Kudsk KA, Li J, et al. Route and type of nutrition
influence mucosal immunity to bacterial pneumonia. Ann Surg.1999; 229:272
–278.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Briskin M, Winsor-Hines D, Shyjan A, et al. Human mucosal addressin
cell adhesion molecule-1 is preferentially expressed in intestinal tract and
associated lymphoid tissue. Am J Pathol.1997; 151:97
–110.[Abstract]
- Butcher EC, Picker LJ. Lymphocyte homing and homeostasis.Science.
1996;272:60
–67.[Abstract]
- Gomez FE, Lan J, Kang W, Ueno C, Kudsk K. Parenteral nutrition and
fasting reduces mucosal addressin cellular adhesion molecule-1 mRNA in Peyer's
patches of mice. JPEN J Parenter Enteral Nutr.2007; 31:1
–6.[Abstract/Free Full Text]
- Ikeda S, Kudsk KA, Fukatsu K, et al. Enteral feeding preserves
mucosal immunity despite in vivo MAdCAM-1 blockade of lymphocyte homing.Ann Surg.
2003;237:677
–685.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Spahn TW, Eugster HP, Fontana A, Domschke W, Kucharzik T. Role of
lymphotoxin in experimental models of infectious diseases: potential benefits
and risks of a therapeutic inhibition of the lymphotoxin-beta receptor
pathway. Infect Immun.2005; 73:7077
–7088.[Free Full Text]
- Stopfer P, Obermeier F, Dunger N, et al. Blocking lymphotoxin-beta
receptor activation diminishes inflammation via reduced mucosal addressin cell
adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic
DSS-induced colitis. Clin Exp Immunol.2004; 136:21
–29.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Stopfer P, Mannel DN, Hehlgans T. Lymphotoxin-beta receptor
activation by activated T cells induces cytokine release from mouse bone
marrow-derived mast cells. J Immunol.2004; 172:7459
–7465.[Abstract/Free Full Text]
- Rumbo M, Sierro F, Debard N, Kraehenbuhl JP, Finke D. Lymphotoxin
beta receptor signaling induces the chemokine CCL20 in intestinal epithelium.Gastroenterology.
2004;127:213
–223.[CrossRef][Medline]
[Order article via Infotrieve]
- Okada T, Ngo VN, Ekland EH, et al. Chemokine requirements for B
cell entry to lymph nodes and Peyer's patches. J Exp Med.2002; 196:65
–75.[Abstract/Free Full Text]
- Kang W, Gomez FE, Lan J, Sano Y, Ueno C, Kudsk KA. Parenteral
nutrition impairs gut-associated lymphoid tissue and mucosal immunity by
reducing lymphotoxin beta receptor expression. Ann Surg.2006; 244:392
–399.[Web of Science][Medline]
[Order article via Infotrieve]
- Sitren HS, Heller PA, Bailey LB, et al. Total parenteral nutrition
in the mouse: development of a technique. JPEN J Parenter Enteral
Nutr. 1983;7:582
–586.[Abstract/Free Full Text]
- Brandtzaeg P, Pabst R. Let's go mucosal: communication on slippery
ground. Trends Immunol.2004; 25:570
–577.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Janu P, Li J, Renegar KB, Kudsk KA. Recovery of gut-associated
lymphoid tissue and upper respiratory tract immunity after parenteral
nutrition. Ann Surg.1997; 225:707
–715.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Johnson CD, Kudsk KA, Fukatsu K, Renegar KB, Zarzaur BL. Route of
nutrition influences generation of antibody-forming cells and initial defense
to an active viral infection in the upper respiratory tract. Ann
Surg. 2003;237:565
–573.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Renegar KB, Kudsk KA, DeWitt RC, et al. Impairment of mucosal
immunity by parenteral nutrition: depressed nasotracheal influenza: specific
secretory IgA levels and transport of parenterally fed mice. Ann
Surg. 2001;233:134
–138.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kudsk KA. Current aspects of mucosal immunology and its influence
by nutrition. Am J Surg.2002; 183:390
–398.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Reese SR, Kudsk KA, Genton L, et al. L-selectin and alpha4beta7
integrin, but not ICAM-1, regulate lymphocyte distribution in gut-associated
lymphoid tissue of mice. Surgery.2005; 137:209
–215.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Yamamoto M, Kweon MN, Rennert PD, et al. Role of gut-associated
lymphoreticular tissues in antigen-specific intestinal IgA immunity. J
Immunol. 2004;173:762
–769.[Abstract/Free Full Text]
- Ware CF. Network communications: lymphotoxins, LIGHT, and TNF.Annu Rev Immunol.
2005;23:787
–819.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lo JC, Basak S, James SE, et al. Coordination between NF-
B
family members p50 and p52 is essential for mediating LTβR signals in the
development and organization of secondary lymphoid tissues.Blood.
2006;107:1048
–1055.[Abstract/Free Full Text] - Genton L, Kudsk KA, Reese S, Ikeda S. Enteral feeding preserves gut
Th-2 cytokines despite MAdCAM-1 blockade. JPEN J Parenter Enteral
Nutr. 2005;29:44
–47.[Abstract/Free Full Text]
- Pascual DW, Stanisz AM, Bost KL. Functional aspects of the
peptidergic circuit in mucosal immunity. In: Ogta PL, Lamm ME, McGhee JR, et
al, eds. Handbook of Mucosal Immunology. New York, NY: Academic
Press Inc; 1994:203
–216.
- Alverdy J, Stera E, Poticha S, et al. Cholecystokinin modulates
mucosal immunoglobulin A function. Surgery.1997; 122:386
–392.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hanna MK, Zarzaur BL, Fukatsu K, et al. Individual neuropeptides
regulate gut-associated lymphoid tissue integrity, intestinal IgA levels, and
respiratory antibacterial immunity. JPEN J Parenter Enteral
Nutr. 2000;24:261
–269.[Abstract/Free Full Text]
- Genton L, Kudsk KA. Interactions between the enteric nervous system
and mucosal immunity: role of neuropeptides and nutrition. Am J
Surg. 2003;186:253
–258.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Zarzaur BL, Wu Y, Fukatsu K, Johnson CD, Kudsk KA. The neuropeptide
bombesin improves IgA-mediated mucosal immunity with preservation of gut
interleukin-4 in total parenteral nutrition-fed mice. Surgery.2002; 131:59
–65.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- DeWitt RC, Wu Y, Renegar KB, King BK, Li J, Kudsk KA. Bombesin
recovers gut-associated lymphoid tissue (GALT) and preserves immunity to
bacterial pneumonia in TPN-fed mice. Ann Surg.2000; 231:1
–8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lorenz RG, Chaplin DD, McDonald KG, McDonough JS, Newberry RD.
Isolated lymphoid follicle formation is inducible and dependent upon
lymphotoxin-sufficient B lymphocytes, lymphotoxin beta receptor, and TNF
receptor I function. J Immunol.2003; 170:5475
–5482.[Abstract/Free Full Text]
- Fagarasan S, Muramatsu M, Suzuki K, Nagaoka H, Hiai H, Honjo T.
Critical roles of activation-induced cytidine deaminase in the homeostasis of
gut flora. Science.2002; 298:1424
–1427.[Abstract/Free Full Text]
- Chin R, Wang J, Fu Y. Lymphoid microenvironment in the gut for
immunoglobulin A and inflammation. Immunol Rev.2003; 195:190
–201.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Yamamoto M, Rennert P, McGhee JR, et al. Alternate mucosal immune
system: organized Peyer's patches are not required for IgA responses in the
gastrointestinal tract. J Immunol.2000; 164:5184
–5191.[Abstract/Free Full Text]
Discussant
Daniel H. Teitelbaum, MD
University of Michigan
The authors, through their own work and work from others, have shown that
LTβR stimulation controls production of IL-4, the adhesion molecule
MAdCAM-1, and the control of other key components of GALT. This pathway is
important in increasing IgA levels and maintaining mucosal defenses. However,
I find one finding in the current paper difficult to understand. The authors
showed that blockade of LTβR did not affect IgA levels. The authors state
that because the animals were fed, IgA levels continued to remain high;
however, I am not sure about this. In particular, the authors made a good case
in the background to show how LTβR is important for many components
needed for IgA production, and nicely showed a decline in MadCAM-1. In the
Discussion section of the paper, the authors begin to address this point, but
it may make sense to continue this area of investigation. In particular, did
the authors examine or plan to examine the changes in IL-4 or IL-10 with
blockade of LTβR? Or did they state plans (in the future) to examine
levels of gastrin-releasing peptide (GRP), etc in mice who underwent LTβR
blockade?
Additionally, the protein expression of MAdCAM-1 and cytokines was not
examined. It may be that the lack of changes in the expression of IgA may be
due to the lack of protein changes with PN and that the effects of PN are
limited to the RNA level. Do the authors have any additional data regarding
this?
Finally, the Peyer's patches have a number of other functional roles aside
from IgA production. Did the authors examine any other functional alterations
in this model of LTβR blockade?
Author's Response
For the first question, IL-4 and IL-10 are known to be Th-2 type
IgA-stimulating cytokines. Recently, we investigated the effects of LTβR
blockade on IL-4 and IL-10 in a pilot study. There were no differences in
levels of these cytokines with or without LTβR blockade. This is probably
because the animals were fed chow and there seem to be other as yet undefined
ways that enteral stimulation preserves IL-4 in the lamina propria to maintain
IgA production besides LTβR. We harvested PPs 3 days after LTβR-Ig
injection in this study. It may be that a longer duration of LTβR-Ig
administration might be needed to affect IgA levels. We have no plans to
measure GRP at this time.
For the next question, we have demonstrated that the protein expression of
MAdCAM-1 is decreased by PN in 2 published experiments. We also have the data
that LTβR blockade depresses MAdCAM-1 protein levels in PP. Therefore, it
seems unlikely that the lack of changes of IgA levels is due to the lack of
protein changes with LTβR-Ig.
For the final question, we did not measure any other functional alterations
in this model of LTβR blockade.
Journal of Parenteral and Enteral Nutrition, Vol. 31, No. 5,
358-365 (2007)
DOI: 10.1177/0148607107031005358

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. A. Kudsk
Jonathan E. Rhoads Lecture: Of Mice and Men... and a Few Hundred Rats
JPEN J Parenter Enteral Nutr,
July 1, 2008;
32(4):
460 - 473.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Kudsk, F. E. Gomez, W. Kang, and C. Ueno
Enteral Feeding of a Chemically Defined Diet Preserves Pulmonary Immunity but Not Intestinal Immunity: The Role of Lymphotoxin {beta} Receptor
JPEN J Parenter Enteral Nutr,
November 1, 2007;
31(6):
477 - 481.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|